Rui Xiong

12PUBLICATIONS
22CO-AUTHORS
Molecular targetsProteins and peptidesCheminformatics and quantitative structure-activity relationshipsGenomics and transcriptomicsFoetal development and medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 10, 2026
Mixed Lineage Kinase Suppression in Triple-Negative Breast Cancer: Identification of a Dual Inhibitor Targeting MLK3 and NAMPT.

|Mar 26, 2026
Discovery of the SARS-CoV-2 Papain-Like Protease Inhibitor MR1-114: From Structure-Based Design to <i>In Vivo</i> Antiviral Efficacy.

Malla Reddy Gannarapu, Divakar Indukuri, Cameron Holberg

|Aug 29, 2024
Do Molecular Fingerprints Identify Diverse Active Drugs in Large-Scale Virtual Screening? (No).

Vishwesh Venkatraman, Jeremiah Gaiser, Daphne Demekas

|Aug 05, 2024
Non-Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease (PLpro): In Vitro and In Vivo Antiviral Activity.

Ganga Reddy Velma, Zhengnan Shen, Cameron Holberg

|Jan 31, 2024
Structure-Guided Design and Synthesis of Pyridinone-Based Selective Bromodomain and Extra-Terminal Domain (BET)-First Bromodomain (BD1) Inhibitors.

Yangfeng Li, Zhengnan Shen, Kiira Ratia

|Jan 22, 2022
XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer.

Daniel R Principe, Rui Xiong, Yangfeng Li

Pageof 2

Frequent Collaborators

10 joint publications

Gregory R J Thatcher

3 joint publications

Ganga Reddy Velma

2 joint publications

Lauren M Gutgesell

2 joint publications

Hyun Lee